Long-term management of symptoms of cerebral arteriosclerosis.
D000368:Aged; D001007:Anxiety / Q000188:drug therapy / Q000209:etiology; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D004357:Drug Synergism; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications; D008134:Long-Term Care; D008297:Male; D009536:Niacinamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011193:Potassium Iodide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012920:Social Behavior Disorders / Q000188:drug therapy / Q000209:etiology
D010919:Placebos; D011193:Potassium Iodide; D009536:Niacinamide